Search

Search Constraints

You searched for: Author/Creator Zustovich, Fable

Search Results

11. Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. (March 2015)

12. Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. (March 2015)

13. Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort. (December 2021)

14. Role of dose exposure and inflammatory status in a single center, real-world analysis of sunitinib in patients with metastatic renal cell carcinoma. (April 2016)

15. Role of dose exposure and inflammatory status in a single center, real-world analysis of sunitinib in patients with metastatic renal cell carcinoma. (April 2016)

16. Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme. (8th October 2014)

17. Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting. (October 2014)

18. Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting. (October 2014)

19. Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting. (October 2014)

20. Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. (October 2020)